Double discovery boosts global quest for leukaemia cures
Snowdome-supported researchers at Peter MacCallum Cancer Centre have discovered how a form of leukaemia fights back against a ground-breaking treatment, providing vital new leads on… Read More
epigenetics
This is my archive
Snowdome supports epigenetic BET inhibitors clinical trial
As today is International Clinical Trials Day (commemorating 20 May 1747, the day on which James Lind started his famous trial comparing treatments for scurvy), Snowdome… Read More
recently approved research projects
Over the last 9 months, Snowdome’s funding efforts have been concentrated on directing just over $1,000,000 into epigenetic treatments for Australians with blood cancers. Snowdome… Read More
supporting ‘global best practice’
Throughout 2013/14, Snowdome was successful in joining several like-minded major donors* to establish the Centre of Research Excellence in Myeloma (CRE-M) in Melbourne. This $3million… Read More
an update on recent accomplishments
We are proud to share that 215 Australian blood cancer patients have gained access to new, cutting-edge therapies since Snowdome formed in 2010. This year… Read More
A Researcher’s Insight – Azacitidine/Eltrombopag study
In a final analysis of the Peter Mac sponsored Azacitidine/Eltrombopag study, haematologist and research fellow, Dr Michael Dickinson, targets myelodysplastic syndromes and gives us a… Read More
‘making hope real’ for patients with MDS
In June this year at the European Haematology Association meeting in Italy, Dr Melita Kenealy, project manager of the Victorian Epigenetics Group, presented the first… Read More
